Seeking Alpha

Arcadium Lithium Stock: Patient Investors Will Be Rewarded

There is little doubt about the key role lithium manufacturers will play in global decarbonization efforts, but due to unfavorable macroeconomic conditions, lithium has been in oversupply recently.
MarketWatch

Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital

The MarketWatch News Department was not involved in the creation of this content. -- Topline data expected by year end -- Head-to-head studies of AL001 versus a marketed lithium carbonate product will ...
Insider Monkey

Raymond James Lifts PT on Standard Lithium (SLI) Stock

Standard Lithium Ltd. (NYSEAMERICAN:SLI) is one of the Best Mining Stocks to Buy According to Hedge Funds. On September 4, Raymond James lifted the price objective on the company’s stock to $4.00 from ...
Psychology Today

Lithium Supplementation for the Psychotherapy Patient

Source: Francesco Mocellin / Used with permission Interest in lithium has been renewed in recent years, not only as a classic mood stabilizer for bipolar illness but also as a potential low-dose ...
Seeking Alpha

Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

Topline data expected by year end Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure ...
WPRI 12

Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of ...